Post

Guardian Article Made Errors regarding Bryant et al. review

Authors have published a detailed rejection of erroneous claims made by a journalist in the Guardian that removal of the Elgazzar study reverses findings for ivermectin for Covid in the Bryant, Lawrie et al. review.

Read or download the letter here

Please Contribute

Let's Get Ivermectin Approved

Safe, cheap, beats Covid

Please support our campaign with a monthly or a single amount to help us keep pressure on authorities to approve the safe drug ivermectin that will help beat covid-19 and save lives around the world.

Bird Group/EBMC Squared is a not-for-profit Community Interest Company (CIC).

All funds received will be invested in our activities to promote public health and wellbeing.

Please contribute

Your monthly or single contribution will help us keep pressure on authorities to approve the safe drug ivermectin that will help beat covid-19 and save lives around the world.